* 中国复星医药H股2196.HK周一早盘一度升3.7%，其A股600196.SS则升3.4%，芍药甘草汤颗粒的药品注册申请获批准。
* 恒生生物科技指数.HSBIO盘中升4%。
* 复星医药公告称，芍药甘草汤颗粒的药品注册申请获国家药品监督管理局批准。
* 年初迄今，复星医药港股累计跌一成，同期A股跌8%。（完）
更多股市简讯请点选CN-CMN-HOT
* 中国复星医药H股2196.HK周一早盘一度升3.7%，其A股600196.SS则升3.4%，芍药甘草汤颗粒的药品注册申请获批准。
* 恒生生物科技指数.HSBIO盘中升4%。
* 复星医药公告称，芍药甘草汤颗粒的药品注册申请获国家药品监督管理局批准。
* 年初迄今，复星医药港股累计跌一成，同期A股跌8%。（完）
更多股市简讯请点选CN-CMN-HOT
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.